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Epstein-Barr virus (EBV) is associated with AIDS-related
lymphomas and other malignancies. We have previously
shown that the proteasome inhibitor bortezomib is an acti-
vator of EBV lytic gene expression and that these effects are
mediated by ER stress and the unfolded protein response
(UPR) [1]. We investigated the relationship between the
induction of UPR and EBV lytic gene expression with a
variety of UPR inducers, as well as the association of their
viral and antitumor effects in a variety of tumor cell lines.
Bortezomib, thapsigargin, and tunicamycin activate the
UPR and EBV lytic cycle. Recently, nelfinavir has also been
reported to lead to ER-stress and the UPR. We found a
dose-dependent relationship with bortezomib and with nel-
finavir for the induction of the UPR markers (Bip, ATF4,
XBP1s, and CHOP10), EBV lytic gene expression (mea-
sured as ZTA RNA), and cell toxicity in Burkitt’s lym-
phoma cell lines.. Blocking ER stress and UPR activation,
by cycloheximide (CHX) treatment or by Bip knockdown,
diminished ZTA induction but had no effect on cellular
toxicity. We also studied EBV lymphoblastoid cell lines
(LCLs). In contrast to the BL cell lines, bortezomib did not
induce ER stress, activate the UPR or lead to EBV lytic gene
expression but was nonetheless toxic to LCLs. These results
indicate that bortezomib and nelfinavir both induce ER
stress and UPR leading to EBV lytic reactivation in BL cells.
UPR induction corresponds with EBV lytic gene induction
but appears to be distinct from cellular toxicity. Our find-
ings suggest that ER stress, UPR and viral activation are clo-
sely linked but may be separable from the cytotoxic effects
of some pharmacologic inducers. Bortezomib and nelfinavir
may serve as laboratory and clinical tools for manipulating
viral gene expression in EBV associated malignancies.
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